Objetivo: Evaluar la correlación entre índices subrogados de resistencia a la insulina y el
valor M obtenido mediante pinza euglucémica-hiperinsulinémica, así como su sensibilidad, …

Background The SARS-CoV-2 outbreak poses a challenge to health care systems due to its
high complication rates in patients with cardiometabolic diseases. Here, we identify risk …

Background COVID-19 has had a disproportionate impact on older adults. Mexico’s population
is younger, yet COVID-19’s impact on older adults is comparable to countries with older …

Objective We developed a novel non-insulin-based fasting score to evaluate insulin sensitivity
validated against the euglycemic–hyperinsulinemic clamp (EHC). We also evaluated its …

Introduction Diabetes and hyperglycemia are risk factors for critical COVID-19 outcomes;
however, the impact of pre-diabetes and previously unidentified cases of diabetes remains …

Background In 2020, Mexico experienced one of the highest rates of excess mortality globally.
However, the extent of non-COVID deaths on excess mortality, its regional distribution …

Familial combined hyperlipidemia (FCHL) is the most prevalent primary dyslipidemia; however,
it frequently remains undiagnosed and its precise definition is a subject of controversy. …

Background: Type 2 diabetes represents an increasing health burden world-wide and its
prevalence in particularly higher in elderly population. Consistent epidemiological evidence …

Background & aims Intra-abdominal and visceral fat (VAT) are risk factors for the development
of cardio-metabolic comorbidities; however its clinical assessment is limited by technology …

Background Whether the metabolically healthy obese (MHO) phenotype is a single, stable or
a transitional, fluctuating state is currently unknown. The Mexican-Mestizo population has a …